HsCRP (high-sensitivity C-reactive protein) and blood glucose are key biomarkers for inflammation and metabolic health. Elevated hsCRP (>2 mg/L) indicates systemic inflammation, often linked to insulin resistance and impaired glucose regulation. Together, they help assess cardiovascular and diabetes risk. Key factors to watch: diet (especially sugar, saturated fats, omega-3s), exercise (aerobic and resistance training lower hsCRP and improve glucose), sleep quality, stress management (cortisol affects both), and body weight (visceral fat drives inflammation). Acute infections can transiently spike hsCRP – do not interpret as chronic. Genetic variants (e.g., IL-1B, COMT, BDNF) have small effects; lifestyle dominates. No specific supplementation is proven by DNA tests. Evidence: strong for clinical utility of hsCRP and HbA1c, moderate for lifestyle interventions. Caution: single measurements are limited; trend monitoring and medical interpretation are essential.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-37611931aaa73c6b19c57d67